APA (7th ed.) Citation

N, R., RS, P., R, C., B, S., S, M., BK, K., . . . D, S. (2025). Preclinical evaluation of sodium copper chlorophyllin: Safety, pharmacokinetics, and therapeutic potential in breast cancer chemotherapy and cyclophosphamide-induced bladder toxicity. Naunyn-Schmiedeberg's archives of pharmacology, 398(10), 14189. https://doi.org/10.1007/s00210-025-04112-z

Chicago Style (17th ed.) Citation

N, Ramani, Patwardhan RS, Checker R, Singh B, Morjaria S, Kumar BK, Gurjar M, Gota V, and Sharma D. "Preclinical Evaluation of Sodium Copper Chlorophyllin: Safety, Pharmacokinetics, and Therapeutic Potential in Breast Cancer Chemotherapy and Cyclophosphamide-induced Bladder Toxicity." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 10 (2025): 14189. https://doi.org/10.1007/s00210-025-04112-z.

MLA (9th ed.) Citation

N, Ramani, et al. "Preclinical Evaluation of Sodium Copper Chlorophyllin: Safety, Pharmacokinetics, and Therapeutic Potential in Breast Cancer Chemotherapy and Cyclophosphamide-induced Bladder Toxicity." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 10, 2025, p. 14189, https://doi.org/10.1007/s00210-025-04112-z.